Advocacy Cannabinoids Safety Sleep 
Cannabis Law Report
MAY 18, 2022
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.
Cannabis Law Report
MAY 18, 2022
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Hemp Roundtable, the hemp industry’s national advocacy organization. “The The methods for both phases were the same.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 23, 2021
Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). Health Europa reports. PROGRAMME.and.ABSTRACTS.
MMJ Recs
NOVEMBER 30, 2023
Studies have indicated that certain cannabinoids found in cannabis, particularly CBD, may have anticonvulsant properties. While anecdotal evidence and individual success stories have sparked interest in using MMJ for seizure control, scientific research plays a crucial role in establishing its safety and efficacy.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Less frequent were references to multiple sclerosis, anxiety and depression, sleep, and HIV. 2016 ; Sznitman et al.
Cannabis Law Report
JUNE 8, 2021
The Minnesota Hemp Association chose to rebrand to the Minnesota Cannabis Association to support legislation of all cannabinoids,” said board member Steven Brown. Reasons that are more popular included improved sleep, reduced anxiety and decreased pain. He owns multiple brands and multiple Nothing But Hemp physical locations.
Expert insights. Personalized for you.
52 
Let's personalize your content